Murine models describe a defined host/pathogen interaction for urinary tract infection, but human cell studies are scant. Although recent human urothelial organoid models are promising, none tolerate urine, the natural substrate of the tissue and of the uropathogens that live there. We developed a novel human organoid from progenitor cells which demonstrates the key structural hallmarks and biomarkers of the urothelium. After three weeks of transwell culture with 100% urine at the apical interface, the surface of the three-dimensional organoid differentiated into enlarged and flattened umbrella cells bearing characteristic tight junctions, asymmetric until membrane plaques, fusiform vesicles and a glycosaminoglycan layer. The umbrella cells also expressed apical cytokeratin-20, a spatial feature of the mammalian urothelium. Further experiments showed that urine itself is necessary for full development, and that undifferentiated cells are urine-tolerant despite the lack of membrane plaques and a glycosaminoglycan layer. Infection with Enterococcus faecalis revealed the expected invasive outcome, including urothelial sloughing and the formation of intracellular colonies similar to those previously observed in patient cells. This new biomimetic model could help illuminate invasive behaviours of uropathogens in the human system, and serve as a reproducible test bed for disease formation, treatment and resolution in patients.
Introduction
UTIs are amongst the most common infectious diseases worldwide, but despite being associated with substantial economic and human cost 1, 2 , they are grossly understudied relative to other human diseases. UTI pathogens are also of particular concern in the global antibiotic resistance crisis, so their burden will only increase in the future 3 . Recurrence of infection even after antibiotic treatment is a particularly troublesome aspect of UTI, usually involving the same strain implicated in the first infection 1, 4 . For example, among healthy young women who suffer from their first UTI, the risk of recurrence within 6 months is 24% 2 . If they had a history of one or more UTIs, the likelihood of recurrence rises to 70% in that same year 2 . In the Canadian surveillance study, 14% of the 30,851 residents with UTI had more than one episode during the two-year study period, and 2% had six or more episodes 5 .
These findings suggest that current treatment regimens are not ideal.
UTI is also problematic in more vulnerable subgroups: the risk of UTI dramatically increases in people with multiple sclerosis (MS) 6, 7 , spinal injury 8 , renal transplant patients 9 and anyone requiring urinary catheterization or other indwelling devices 10 . In fact, UTIs have accounted for 10.5 million ambulatory care visits in 2007 in the United States 11 , with the direct and indirect costs being estimated at more than US$3.5 billion. This is likely to rise with the ageing global population and the emerging threat of antibiotic resistance. Finally, amongst the elderly, UTIs are one of the most commonly diagnosed infections, accounting for over a third of all nursing home-associated infections 12 . More frequent UTI in these cohorts is not merely bothersome; UTI is known to exacerbate MS 13 , lead to confusion and falls in the elderly 14 , and increase the risk of organ rejection in renal transplant patients 15 .
Furthermore, catheter-associated UTI carries an increased risk of urosepsis 16 , and bacteriuria in pregnant women is associated with preterm birth and other maternal morbidities 17 .
To understand why urinary infections are often recalcitrant to treatment, the pathogens must be studied in their unique environment. The urinary bladder is lined by a specialised transitional urothelium comprising 3-7 layers of cells: basal cells (above the basement membrane), intermediate cells (above basal cells) and morphologically distinct, highly specialised, often binucleated umbrella cells at the apical surface, which face outward into the bladder lumen 18 . These enlarged, flattened urothelial umbrella cells (or 'facet cells') partition urine and are thought to act as a powerful barrier to protect underlying tissue from harmful waste compounds 19 . They elaborate a highly-durable apical asymmetric unit membrane (AUM) consisting of thousands of regularly arrayed plaques or 'facets' approximately 16.5 nm across made up of four mannosylated transmembrane glycoproteins called uroplakins (UP) [19] [20] [21] .
In addition to the uroplakin family, the urothelium also elaborates a mucopolysaccharide-rich layer of glycosaminoglycans (GAG) which are believed to protect the bladder from infection and urine-born irritants 22 , of which chondroitin sulphate, heparan sulphate, hyaluronic acid, dermatan sulphate and keratin sulphate are the most studied 23 . Chondroitin sulphate, in particular, is believed to play a key role in urothelial barrier function and exhibits luminal and basal expression in both human and porcine bladders 24 . In contrast, only heparan sulphate was detected in the luminal portion of calf bladders, elucidating possible differences between species 25 .
A significant proportion of research on the urothelium has been conducted using mouse models 21, 26 . These findings have been widely translated into human oncology to locate the primary origin of metastatic tumours 27 and to understand the biology of UTI 26 . While invaluable in many cases and necessary for regulatory approval of drugs, some animal models of human disease, the majority of which are murine, have received widespread criticism in recent years [28] [29] [30] [31] [32] . The limitations of murine models are particularly evident when modelling human infection and attempting to treat this induced pathology with novel antimicrobials 28 . In such studies, mice are frequently infected with far higher quantities of log-phase bacteria than would be evident in a slow-growing chronic human infection, and the pharmacokinetic profiles of a given drug are challenging to translate to humans 28, 33 .
In the case of urinary infection studies, it is known that the human and mouse bladder urothelium differ in a number of structural ways. The markers expressed are similar, but in contrast to the murine model, human bladder urothelial marker expression exhibits a relationship with the level of cellular differentiation 21, 34 . For example, the healthy human bladder has been shown to elaborate cytokeratin 20 at the luminal surface whereas cytokeratin 8 is expressed throughout the cells of the urothelium 18, 35 . The incorrect spatial expression of cytokeratin 20 by terminally differentiated umbrella cells has been linked to painful bladder syndrome and neurogenic bladder and is thought to predispose people with MS to chronic UTI 6, 18, 35 . Studies also suggest that murine and human bladders can differ in their innate immune response to uropathogens (for example in their expression and use of Toll-like receptors 36 ). Moreover, rodent bladders differ from those of humans functionally.
While larger mammals (>3Kg) share a scalable urinary capacity and consistent voiding duration, rodents urinate almost constantly, bringing into question whether their bladders are a true storage organ 37 . The multiple disparities between the rodent and human bladders raise the possibility that relying so heavily on the former could be problematic for understanding UTI in the latter. Indeed, we have recently shown that the host/pathogen interactions of two common uropathogens, E. coli and Enterococcus faecalis (E. faecalis), seem to differ between mice and chronically infected older patients 38 , although it is not clear whether this is due to the model or the older patient group.
Given these species differences, there is a need for alternative human-based models to augment the impressive body of elegant in vivo mouse experiments into UTI biology. Human bladder cancer cell lines grow readily and are tractable, but they are genetically abnormal and, therefore, bear little resemblance to primary urothelial cells in terms of structure and function. In particular, although some retain the ability to form a stratified organoid, they do not form an organised and differentiated 3D architecture 39, 40 , which is crucial not least for understanding host/pathogen interaction, as uropathogens are proposed to invade the urothelium via binding to factors only present in terminally differentiated umbrella cells 26 .
On the other hand, recent years have seen advances in three-dimensional tissue engineering.
A number of promising 3D urothelial models have been described in the literature, the majority of which have been discussed in a comprehensive review by Baker et al. (2014) 22 .
Briefly, existing bladder models are produced using one of three broad culture techniques: (1) organ culture of intact biopsies or explant culture; (2) culture of urothelial cells naturally shed into the urine or harvested from biopsies; and (3) organotypic culture whereby normal urothelial cells are stimulated to form 3D organoids on filter inserts 22 . Although arguably the most relevant model system, organ culture of intact human tissue is time consuming, yields a finite amount of experimental material and requires fresh human tissue 22, 41 . Due to these limitations, a number of researchers have used rodent bladder biopsies. However, interspecies differences imply that these models may not be biologically germane 42 . More practical is the cultivation of human urothelial cells isolated from host urine or biopsies which, when grown using a specialist protocol, have been shown to maintain the ability to stratify, differentiate and develop a robust barrier function in vitro 22, [43] [44] [45] [46] .
Although these models constitute impressive alternatives to animal models, to our knowledge, none last more than a few hours in urine in vitro 22 , the natural apical substrate of this tissue. Therefore, the effect of urine exposure on urothelial differentiation and GAG expression remains unclear. Moreover, none of the human-derived urothelial biomimetics have been reported to correctly express cytokeratin 20 at the apical surface 35 . To address these limitations, we worked to develop a urine-tolerant organotypic human urothelium that could be used as a platform studying for host/uropathogen interactions, treatment, and resolution in humans.
Materials and methods

Human Primary progenitor cell expansion and handling in 2D
Commercially available human bladder epithelial progenitor cells (HBEP, Cell N Tec) 47 and their spontaneously immortalised, non-transformed counterparts (HBLAK, Cell N Tec) were supplied in frozen aliquots containing ~5x10 5 cells at passage 2 and ~0.5x10 5 at passage 25 respectively. Cells were isolated from bladder trigone biopsies from male patients undergoing surgery for benign prostatic hyperplasia. HBEP cells are guaranteed to grow for a further 15 population doublings before senescing whereas HBLAK cells, although spontaneously immortalised, should not be differentiated into 3D cultures once they have exceeded a passage number of 40-50. Both cell types were cultured identically, with the exception of slight differences in incubation time between passages, due to the slightly increased rate of cell division exhibited by HBLAK cells.
Thawed cells were seeded (~300 cell clumps / cm 2 ) into pre-warmed and equilibrated lowcalcium, high-bovine pituitary extract, primary epithelial medium (CnT-Prime, Cell N Tec) in 9cm polystyrene dishes and incubated at 37°C in a humidified incubator under 5% CO2.
Culture medium was replaced after overnight incubation to remove residual dimethyl sulfoxide (DMSO). Antibiotics were not added to culture medium at any point due to adverse effects on cytodifferentiation, metabolism and morphology 48 . Furthermore, trypsin is known to damage primary cells, so Accutase solution (Innovative Cell Technologies) was used to detach cells at all stages of experimentation 49 . Cells were allowed to expand to ~70% confluency before freezing batches of cells at a density of ~1x10 6 cells/ml in defined freezing medium (CnT-CRYO-50, Cell N Tec) in preparation for later experiments. Cells were not allowed to become fully confluent during cell expansion in an effort to maintain a proliferative phenotype.
Differentiation of 3D human urothelium in vitro
In preparation for organotypic culture, previously frozen progenitor cells were thawed and expanded on 9cm culture dishes as above. Once 70-80% confluent, the cells were washed briefly with calcium-and magnesium-free phosphate buffered saline (PBS, Sigma-Aldrich) and incubated at 37°C in ~3ml of pre-warmed Accutase solution for 2-5min. The dishes were lightly tapped and detached cells re-suspended in 7ml of warm CnT-Prime. After centrifugation at 200xg for 5min, the supernatant was removed and the pellet re-suspended in fresh CnT-Prime. This cell suspension was counted whilst allowing the cells to equilibrate for 3min at room temperature. 2x10 5 cells in 400µl of CnT-Prime (internal medium) were added to 6 12mm 0.4µm pore polycarbonate filter (PCF) inserts (Millipore) standing in 6cm culture dishes containing ~3ml of fresh pre-warmed CnT-Prime medium (external medium, level with insert filters). A further 8ml of CnT-Prime medium was added to the 6cm dish (external to the filter inserts) until internal and external fluid levels were the same. The 3D culture inserts were incubated for 3-5 days until 100% confluent. Confluency was determined through the fluorescent staining of 1 insert and visualisation under epi-fluorescence microscopy (see section below). Once deemed confluent, internal and external medium was removed and replaced with low-BPE, calcium-rich (1.2mM) differentiation barrier medium (CnT-Prime-3D, Cell N Tec) to promote differentiation. Subsequent to overnight incubation, the internal medium (apical surface of cell culture) was removed and replaced with filtersterilised human urine pooled from healthy volunteers of both genders to aid terminal differentiation into umbrella cells. The external CnT-Prime-3D medium and the internal human urine were replaced every 3 days and the culture incubated for 14-24 days at 37°C in 5% CO2.
To explore the effect of urine on differentiation in 2D, the HBLAK cells were seeded on 8well permanox Lab-Tek slides (Sigma-Aldrich) and grown to confluency. The cells were then exposed to CnT-Prime-3D medium alone, 25%, or 50% sterile human urine diluted in CnT-Prime-3D for 72 hours at 37°C in 5% CO 2 . To analyse the effect of urine on HBLAK organoid formation, cells were grown to confluency on filter inserts as above. The basal compartment was treated with CnT-Prime-3D throughout, however, the apical compartment was filled with either CnT-Prime-3D alone, 50% sterile human urine diluted in CnT-Prime-3D or 100% urine. The specified medium or urine was changed every 3 days and the culture incubated for 14 days at 37°C in 5% CO2.
Characterisation of the 3D urothelium
Prior to fluorescent staining and immunofluorescence (IF), filter inserts were carefully transferred to 8-well plates (Nunc) and submerged in 4% methanol-free formaldehyde (Thermo Scientific, Fisher Scientific) in PBS overnight at 4°C. After fixation, the filter inserts were kept at 4°C in 1% formaldehyde in sealed containers in preparation for processing.
To determine confluency and analyse morphology, the pre-fixed tissue was permeabilised in 0.2% Triton-X100 (Sigma-Aldrich) in PBS for 15 minutes at RT followed by a single wash with PBS. The cells were stained with TRITC or Alexa Fluor-633-conjugated phalloidin In preparation for imaging, filters were carefully removed from inserts using a scalpel, mounted with FluorSave reagent (Calbiochem), and a coverslip fixed in place with clear nail varnish. Lab-Tek slide wells and gaskets were carefully removed prior to the addition of FluorSave and a coverslip as above. For scanning electron microscopy (SEM), the samples were fixed and dehydrated as above.
Electron microscopy
Samples were then incubated in Tetramethylsilane for 10 min and air dried before mounting on stubs and sputter-coated with gold.
Experimental infection of the human urothelial organoid
A single strain of Enterococcus faecalis (E. faecalis) originally derived from a patient with chronic UTI 38 along with uropathogenic Escherichia coli (E. coli) shown previously to be invasive in murine models (UTI89, kindly donated by the Hultgren laboratory, Washington University, St. Louis), were grown aerobically in a shaking incubator at 37°C for 24 hours.
Once a batch of 6 HBLAK 3D urothelial cultures had reached 14 days of growth, 1.1x10 5 colony-forming units of each bacteria were added to the filter-sterile human urine at the apical liquid-liquid interface of each culture. The experimentally infected cultures were incubated for 2 hours at 37°C under 5% CO2. The 3D culture filter inserts were washed with PBS before fixation and staining as above.
Imaging and Analysis
We performed epi-fluorescence microscopy on an Olympus CX-41 upright microscope, and confocal laser scanning microscopy on Leica SP5 and SP2 microscopes. Images were processed and analysed using Infinity Capture and Analyze V6.2.0, ImageJ 1.50h 50 and the Leica Application Suite, Advanced Fluorescence 3.1.0 build 8587 Software.
TEM was conducted using a Jeol 1200-Ex digital image capture system with a side mount 2Kv AMT camera. SEM was performed using a Jeol JSM-5300 fitted with a Semafore digital image capture system.
Results
HBLAK and HBEP can form morphologically correct urothelial organoids
HBEP cells were derived from normal human bladder biopsies by CellNTec and provided commercially in cryovials. We also grew HBLAK cells, which are spontaneously immortalised but not transformed version of HBEP available from the same company. These latter cells retain the ability to differentiate but have increased longevity without senescing.
On thawing, both cell types were seeded on plastic in fully defined, serum-free, BPE (FIG 1 a,b ).
The HBLAK tissue was also morphologically similar to native human urothelium, but in contrast, likely due to increased rate of growth, these produced approximately 5-7 cell layers with multiple layers of intermediate cells (FIG 1 c,d) . Optical slices at the basal region of the HBEP and HBLAK organoids respectively showed the typically small, tightly-packed and spheroid morphology of urothelial basal cells (FIG 1 e,g) . Basal cells in the HBLAK organoid (~ø10µm) appeared to be slightly smaller than those in the HBEP culture (~ø20µm) (FIG 1 e,g) . Similarly, single optical slices at the apical regions of the HBEP and HBLAK organoids showed the formation of a large, flat and often hexagonal cellular morphology typical of well-differentiated umbrella cells (FIG 1 f,h) which were occasionally binucleate (data not shown).
In summary, both models are morphologically similar to native human bladder tissue and formed well-differentiated umbrella cells at their apical surface. Moreover, both models were exposed to sterile human urine for several weeks (14-25 days) without exhibiting any signs of toxicity.
HBLAK and HBEP organoids exhibit key biomarkers of the human urothelium
We characterised the HBEP and HBLAK human urothelial organoids further by targeting urinary tract-specific antigen expression using indirect IF in conjunction with high-resolution laser scanning confocal microscopy. The resulting organoids had the correct spatial expression of several key biomarkers. Studies exploring cytokeratin (CK) expression in normal human bladders have shown a relationship between the level of cytodifferentiation and sub-type CK expression 18 . Both HBEP-and HBLAK organoids exhibited correct spatial expression of CK8 and CK20; specifically, CK8 was expressed throughout the strata of the in vitro tissues whereas CK20 was expressed preferentially by the umbrella cells at the apical surface (FIG 2 a,b,c,d) . In contrast to the rodent bladder, muscarinic receptors are expressed throughout the human urothelium 51, 52 . This finding was echoed in our model with evidence of muscarinic receptors M2 and M3 expressed in all cell layers of both organoids (FIG 2 e,g) .
Uroplakin-III (UP3), an indispensible part of the asymmetric unit membrane 53 , was present at the apical surface of the HBEP (FIG 2 f) and HBLAK (Fig 2 h) , in a pattern similar to that previously reported by our group in shed urothelial cells from infected patients 39 .
HBLAK organoids possess correct topographical and ultrastructural features
Given these promising results, we developed the more tractable and thicker HBLAK urothelial mimetic model, using scanning electron microscopy (SEM) and transmission electron microscopy (TEM) to analyse its ultrastructure, organisation and overall topography.
Low-power SEM showed that the HBLAK cells elaborated distinct multi-layered 'islands' of organoid formation with umbrella cells at their surface surrounded by undifferentiated basal cell-like monolayers (FIG 3 a) . The surface of each 'island' exhibited very large (up to ~80µm), often hexagonal umbrella cells; however, areas of disorganised hyperplasia were often noted (FIG 3 b) . On closer inspection, SEM micrographs showed evidence of tight junction formation (FIG 3 c) 54 and characteristic microplicae or 'hinges' at the apical surface of each umbrella cell (FIG 3 d) 54, 55 . Orthogonal sections of the fully differentiated organoid 'islands' were analysed using TEM. As with the laser scanning confocal imaging, TEM elucidated distinct layers of basal, intermediate and umbrella cells (FIG 3 e) . Rigid plaques could be seen residing between the 'hinges' at the apical surface of the umbrella cells (FIG 3   f) 54, 55 along with the specialised fusiform vesicles (FIG 3 g) necessary for trafficking uroplakins 56 . In contrast, TEM analysis of the small undifferentiated cells making up the monolayers surrounding the organoid 'islands' did not exhibit hinges, plaques or fusiform vesicles (FIG 3 a,h,i) . Taken together, these observations suggest that the fully differentiated 'island' regions of the organoids possess the key features expected of a human urothelium.
Urine strongly influences HBLAK differentiation, organoid development and GAG formation
As shown above, the HBLAK organoid expresses key urothelial markers and is morphologically reminiscent of native human urothelium. Of significant importance, however, is the tolerance exhibited by these cultures to urine. In this group of experiments we investigated whether urine is merely tolerated or indeed necessary for differentiation in 2D, organoid formation and the elaboration of a GAG layer. To achieve this, we exposed the cells, in 2D and 3D, to various dilutions of sterile human urine before examining microscopically.
When grown as 2D monolayers on chamber slides, the HBLAK cells exhibited a marked dose response to urine after 72 hours. Cells grown in high calcium medium alone took on a small, tightly packed basal cell-like appearance with well-formed intercellular junction (FIG   4 a) . With the addition of 25% human urine a small proportion of the cells began to differentiate and exhibit a large umbrella cell-like morphology, but intercellular junctions were partially disrupted (FIG 4 b) . After 72 hours in 50% sterile human urine, extensive colonies of HBLAK cells took on a large, flat umbrella cell morphology. However, intercellular junctions were shown to be almost entirely compromised, possibly because increased urine came at the expense of calcium concentration (FIG 4 c) .
Strikingly, we found human urine to be necessary for organoid formation and the elaboration of a GAG layer in HBLAK cells. Cells cultured for 14 days on filter inserts with high calcium medium in the basal and apical compartments showed no stratified organoid formation, little heparan sulphate, and no detectable expression of chondroitin sulphate (FIG 4 d) . Moreover, these cells appeared to exhibit a degree of anaplasia, by dedifferentiating into a more 'spindle-like' multipotent progenitor cell-like morphology (FIG 4 d, and data not shown). In contrast, HBLAK cells cultured in 50% or 100% human urine at the apical surface produced 'islands' of organoid formation between 3 and 6 cell layers thick (FIG 4 e,f ). Furthermore, both urine dilutions stimulated the expression of a heparan and chondroitin sulphate-rich GAG layer at the urine-umbrella cell interface (FIG 4 e,f) . Taken together with the data in Figure 3 , these experiments show that urine is an indispensible effector of full urothelial differentiation in this model. Nevertheless, despite a lack of GAG layer and AUM, undifferentiated cells remain viable for long periods in urine, which suggests that these "barriers" are not required for urine tolerance.
The HBLAK organoid is a promising model for infection, including cell invasion
Thus far we have characterised the HBLAK-derived human urothelial organoids and highlighted similarities to native human tissue. In addition, we found that human urine, the natural apical substrate of the urothelium, evokes a physiological response which would appear to be vital for stratification, differentiation and the elaboration of a GAG layer. Next, we challenged the organoid with known uropathogens to better understand the infective process and to further validate this novel system as a test-bed for the study of host/pathogen interactions.
First, we infected the HBLAK organoid with patient-isolated E. faecalis 38 . E. faecalis is commonly implicated in chronic UTI and is frequently associated with multi-drug resistance, hospital-acquired infection, and catheter associated biofilm formation; we previously demonstrated that it exhibits intracellular invasion in patient cells 38,57-64 . When we inspected the cultures two hours after infection, we found that E. faecalis exhibited robust tropism in this model, with the resulting adherent colonies relatively loosely packed (FIG 5 a) . As with human patients suffering from acute and chronic UTI 38 , the umbrella cell layer was shed in response to bacterial insult, leaving an uneven surface of basal and intermediate cells (FIG 5   a) . Inspection of supernatants post-infection revealed extensive shed umbrella cells highly reminiscent of those seen in the urine of infected patients. Significantly, in the tissue that remained, we saw frequent examples of large intracellular bacterial colonies (FIG 5 b,c,d) within the superficial layer of cells, similar in morphology to those we previously observed in material from patients 38 . These findings suggest that the model recapitulates the host/pathogen interaction of E. faecalis with its human host.
Next, we infected the HBLAK organoid with a strain of uropathogenic E. coli previously shown to be invasive in murine studies (UTI89). This bacteria exhibited marked tropism in this system with extracellular biofilm formation covering a significant proportion of the model (FIG 5 e) . As seen in patients, and in the E. faecalis infected organoid described above, the umbrella cell layer was sloughed, resulting in an irregular stratum of basal and intermediate cells (FIG 5 e) . This cell shedding appeared to allow the bacteria to gain access to deeper tissue layers where it could be seen residing extracellularly between basal and intermediate cells (FIG 5 f,g,h) . In contrast to E. faecalis, however, despite the examination of numerous samples, we found no evidence of intracellular E. coli (FIG 5 f,g,h) . This lack of intracellular invasion, in conjunction with extensive superficial biofilm behaviour, again echoes what we previously showed in shed patient cells and human T24 cell models 38 .
In summary, this model, to our knowledge, represents the first urine-tolerant human bladder organoid produced in vitro. This tissue is morphologically similar to normal human bladder urothelium and expresses a number of key markers in the correct spatial compartments in response to exposure to urine. As with patients, this organoid rapidly sheds the umbrella cell layer in response to bacterial insult. Moreover, E. faecalis and E. coli displayed phenotypes supporting our previous findings in shed patient cells 38 .
Discussion
The development and use of in vitro human tissue mimetics is thought to be accelerating the drug discovery process 65 and improving our understanding of human tissue morphogenesis.
Due to improved physiological relevance, such models could even reduce the use of animal models in the coming years 66 . Here, we present a urine-tolerant, three-dimensional urothelial organoid derived from human progenitors that is easy to grow from commercially-sourced, quality-controlled materials, displays key hallmarks of the human urothelium, and may serve as an alternative to the murine model. If desired, it should also be possible to create similar urine-tolerant organoids from fresh human biopsies using the protocols and defined medium we describe.
Morphologically, the HBEP and HBLAK cells produced tissue reminiscent of what is described in the human bladder 18, 19, 26 . Moreover, both culture types developed a fully differentiated umbrella cell layer, a hallmark of the bladder urothelium 21 Patients with overactive bladder symptoms are frequently treated with antimuscarinics which target muscarinic receptors in the detrusor and urothelium 51 . Crucially, rodent bladder urothelial cells do not express muscarinic receptors 52 . In the case of the HBEP and HBLAK tissue grown in this study, muscarinic receptors M2 and M3 were detected throughout the urothelial cell layers, further supporting its physiological relevance and potential use in the development of novel therapeutic agents for the bladder symptoms of MS and other neurogenic disorders.
More detailed analysis revealed several interesting aspects to our HBLAK organoid model.
First, EM showed that the tissue was not homogenously differentiated; instead, the surface consisted of three discrete zones: 'valleys' of undifferentiated monolayer; 'plateaus' of fully differentiated 3D tissue; and 'mountains' of hyperplasia. Second, focusing on the plateaus, our EM imaging shows all the aspects expected from a human urothelium, including morphologically distinct layers, the enlarged flat nature of the distended umbrella cells, the characteristic hinges and plaques associated with the AUM, and the fusiform vesicles responsible for trafficking during bladder filling and emptying phases. Importantly, these key hallmarks were entirely absent from the zone of undifferentiated cells, showing a correlation with differentiation status. Third, inspection of GAG layer markers revealed that the presence of urine correlates with its elaboration, parallel to differentiation and organoid formation.
Intriguingly, when we tested the barrier function of the organoid by several methods, including transepithelial resistance and fluorescent dextran permeability (data not shown), we found a lack of what is traditionally thought of as urothelial "barrier function". We presume that this result was caused by the sporadic presence of undifferentiated cells across the tissue, which in essence short-circuits the apicobasal electrical potential difference. This result, taken together with the fact that the non-differentiated zone devoid of AUM and GAG can grow for several weeks in the presence of urine, strongly suggests that AUM and GAG are not required for urine tolerance, and that something intrinsic in the cells themselves confer resistance to its toxic effects. It also suggests that apical urine is necessary for full differentiation. Whilst it may be the case that urine is not sufficient for differentiation, given the presence of the undifferentiated 'valleys', it may also be the case that a subset of HBLAK cells are subtly different. Further exploration into the nature of urine tolerance and the effect of urine and other media components on differentiation and hyperplasia are warranted. In the meantime, researchers performing image-based studies should be able to focus on areas of the organoid corresponding to their desired level of differentiation.
Sloughing of umbrella cells from the epithelial lining into the urine is known in both mice and humans to be a common response to infection [68] [69] [70] [71] [72] . In mouse model experiments, this dramatic cell shedding response leaves a gap in the epithelial layer, exposing naive transitional cells (proximal to the submucosal coat) to de novo uropathogenic E. coli (UPEC) invasion, a process which has been proposed, through an actin-gated pathway, to create quiescent intracellular reservoirs (QIR) responsible for latent recurrent and low-level chronic infection in mice 26, 71, [73] [74] [75] [76] . Although QIR have not been observed in human patients, there is indirect evidence to suggest bacterial persistence in the human urothelium 4, 26, 71, 74, 75, 77, 78 . Data from human recurrent UTI demonstrate that 68% of bacteriological recurrence is caused by identical bacterial strains to that of the index infection 4 . Although it could be argued that these relapses are caused by reintroduction of pathogens from faecal flora 79 , same-strain infections can occur up to 3 years later 78 and the application of daily topical antibiotics to the perineum did not prevent recurrent episodes 77 . Further studies are needed to understand the long-term persistence of UTI pathogens in the host.
Our model shows great promise for studying the host/pathogen interactions of UTI in a human-cell system. We previously reported the discovery of intracellular colonies of E. faecalis harbored within the urothelial cells of chronic UTI patients 38 . In addition, the uropathogenic strains of E. faecalis isolated from these patients were able to invade a T24 bladder cell line 38 . This finding was echoed in our urothelial organoid, where E. faecalis formed significant intracellular colonies within the intermediate and basal cells of the urothelial mimetic after its umbrella-cell layer had been jettisoned. These results further support the notion that E. faecalis exhibits an intracellular phenotype.
In many murine studies, uropathogenic E. coli has been shown to invade urothelial cells as part of a well-described intracellular lifestyle 26 . As a result, it is now widely accepted that UPEC exhibits an intracellular phase in UTI patients. However, since the initial report of intracellular "pods" in the mouse model in 2003 73 , to our knowledge only four papers 72 80 81 82 have reported IBC in the shed cells of human UTI patients, only two of which (representing studies of one and 49 children respectively) deployed orthogonal analysis at the Z resolution necessary to minimise point spread function and pinpoint the bacteria to an intracellular compartment 83 80,81 . Another report has shown that UPEC isolated from women with acute cystitis were competent to form IBC in mice 84 , but this evidence is not direct proof of their presence in the original patients. Hence, more studies on the universality of intracellular UPEC in human UTI would be welcomed.
In our model, the same strain of UPEC used for murine studies of IBC (UTI89) did not invade the cells of our human organoid, but instead formed dense biofilm covering a significant proportion of the organoid surface, which may be equally problematic for treatment. This result agrees with our previous work 38 which revealed superficial biofilms but again, no evidence for E. coli IBC. It is possible that the timings or other conditions of infection were not optimized for invasion with this strain of bacteria, and it remains a possibility that some requisite aspect of the host cell is absent in our model. In view of the significant differences between the human and rodent bladder, we propose that further studies in patients are required before concluding whether UPEC habitually invades human cells. On the other hand, if experimental conditions could be discovered that allowed UPEC to invade our organoid, the ease of creating tissue at various stages of differentiation would serve as an excellent model for understanding the creation, formation, and resolution of quiescent intracellular reservoirs, which up to this point have remained elusive in humans.
In conclusion, current advances in 3D tissue culture enabled us to grow physiologically relevant, organotypic human models of the bladder. Human bladder biomimetics could be used as a reproducible test bed for chronic infective disease formation, treatment, and resolution in humans.
